The GnRH receptor can activate the Gi pathway in uterine leiomyosarcoma, as well as ovarian and endometrial carcinomas, resulting in down-regulated gene transcription and anti-proliferative effects in cancer cells [74]. The gene discussed is GNRHR; the disease is endometrial carcinoma.